Dr. Markus Hosang (Director)
BioMed Partners
Dr. Markus Hosang received his M.S. and Ph.D. degrees in Biochemistry from the ETH in Zurich and pursued his postgraduate training at Stanford University Medical School and the University of Washington in Seattle. In 2005 Dr Markus Hosang joined BioMedPartners as a General Partner. Since then, he has served on the boards of many European biotech and medtech companies, some of which have been sold or gone public very successfully.
Dr. Hosang has a strong pharmaceutical background and is very experienced in venture capital. Previously, he served as Venture Partner at MPM Capital, where he was co-responsible for the European deal flow and managed the European office in Munich.
Before joining MPM in 2002, he was at Roche, where he served for nearly 20 years in several senior management positions in the Pharma R&D organization, including VP and Director of the International Pharma Research Strategy Unit and Chief of Staff to the President of Roche Global R&D.
Dr. Hosang served on the Global Board of R&D Directors and the Pharma Portfolio Board. Subsequently, he became VP and CSO of Genetics and Integrated Medicine and a member of the Roche Genetics Executive Committee.
